サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Global Wilson’s Disease Drugs Market 2019-2023

ウィルソン病治療薬の世界市場 2019-2023

レポート概要

市場について

戦略的提携の増加は市場成長に役立ちます。製薬企業は、ウィルソン病治療薬の開発を目的に戦略的提携を進めており、これにより新薬の研究開発活動が活発化しています。

ウィルソン病治療薬市場は、2023年までに約6%のCAGRで成長すると予測されます。

市場概要

  • 患者支援プログラムの導入増加

患者支援プログラムは、健康保険または処方箋薬の補償のない患者が必要とする薬物を得るのを援助するために導入されました。

  • 高額な治療費

キレート化剤の利点にもかかわらず、これらの薬の価格が、市場成長への課題となっています。キレート化剤の高いコストによって、キレート化剤治療への患者の固執が低くなり、世界のウィルソン病治療薬市場の成長を妨げると見込まれます。

市場勢力図

本市場は、Bausch Health Companies社やMylan社などのいくつかの企業の存在で断片化しています。戦略的提携の増加や患者支援プログラムの導入増加といった要因が、ウィルソン病治療薬製品にかなりの成長機会を提供するでしょう。

主要企業

  • Bausch Health Companies
  • Mylan
  • Teva Pharmaceutical Industries
  • ツムラ(TSUMURA)
  • Recordati

レポート詳細

目次

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis

PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
Chelators - Market size and forecast 2018-2023
Minerals - Market size and forecast 2018-2023
Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
Americas - Market size and forecast 2018-2023
EMEA - Market size and forecast 2018-2023
APAC - Market size and forecast 2018-2023
Key leading countries
Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
Market drivers
Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario

PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Bausch Health Companies
Mylan
Recordati
Teva Pharmaceutical Industries
TSUMURA

PART 14: APPENDIX
Research methodology
List of abbreviations

PART 15: EXPLORE TECHNAVIO

図表
Exhibit 01:Global rare disease drugs market
Exhibit 02:Segments of global rare disease drugs market
Exhibit 03:Market characteristics
Exhibit 04:Market segments
Exhibit 05:Inheritance of Wilson's disease
Exhibit 06:Market definition - Inclusions and exclusions checklist
Exhibit 07:Market size 2018
Exhibit 08:Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09:Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10:Five forces analysis 2018
Exhibit 11:Five forces analysis 2023
Exhibit 12:Bargaining power of buyers
Exhibit 13:Bargaining power of suppliers
Exhibit 14:Threat of new entrants
Exhibit 15:Threat of substitutes
Exhibit 16:Threat of rivalry
Exhibit 17:Market condition - Five forces 2018
Exhibit 18:Product - Market share 2018-2023 (%)
Exhibit 19:Comparison by product
Exhibit 20:Chelators: Mechanism of action
Exhibit 21:Chelators - Market size and forecast 2018-2023 ($ millions)
Exhibit 22:Chelators - Year-over-year growth 2019-2023 (%)
Exhibit 23:Minerals - Market size and forecast 2018-2023 ($ millions)
Exhibit 24:Minerals - Year-over-year growth 2019-2023 (%)
Exhibit 25:Market opportunity by product
Exhibit 26:Customer landscape
Exhibit 27:Market share by geography 2018-2023 (%)
Exhibit 28:Geographic comparison
Exhibit 29:Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 30:Americas - Year-over-year growth 2019-2023 (%)
Exhibit 31:Top 3 countries in Americas
Exhibit 32:EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 33:EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 34:Top 3 countries in EMEA
Exhibit 35:Country_Legend_2
Exhibit 36:APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 37:APAC - Year-over-year growth 2019-2023 (%)
Exhibit 38:Top 3 countries in APAC
Exhibit 39:Country_Legend_3
Exhibit 40:Key leading countries
Exhibit 41:Country_Legend_16
Exhibit 42:Market opportunity
Exhibit 43:Impact of drivers and challenges
Exhibit 45:Impact of drivers and challenges
Exhibit 46:Vendor landscape
Exhibit 47:Landscape disruption
Exhibit 48:Vendors covered
Exhibit 49:Vendor_analysis
Exhibit 50:Vendor classification
Exhibit 51:Market positioning of vendors
Exhibit 52:Bausch Health Companies - Vendor overview
Exhibit 53:Bausch Health Companies - Business segments
Exhibit 54:Bausch Health Companies - Organizational developments
Exhibit 55:Bausch Health Companies - Geographic focus
Exhibit 56:Bausch Health Companies - Segment focus
Exhibit 57:Bausch Health Companies - Key offerings
Exhibit 58:Bausch Health Companies - Key customers
Exhibit 59:Mylan - Vendor overview
Exhibit 60:Mylan - Business segments
Exhibit 61:Mylan - Organizational developments
Exhibit 62:Mylan - Geographic focus
Exhibit 63:Mylan - Key offerings
Exhibit 64:Mylan - Key customers
Exhibit 65:Recordati - Vendor overview
Exhibit 66:Recordati - Business segments
Exhibit 67:Recordati - Organizational developments
Exhibit 68:Recordati - Geographic focus
Exhibit 69:Recordati - Segment focus
Exhibit 70:Recordati - Key offerings
Exhibit 71:Recordati - Key customers
Exhibit 72:Teva Pharmaceutical Industries - Vendor overview
Exhibit 73:Teva Pharmaceutical Industries - Business segments
Exhibit 74:Teva Pharmaceutical Industries - Organizational developments
Exhibit 75:Teva Pharmaceutical Industries - Geographic focus
Exhibit 76:Teva Pharmaceutical Industries - Segment focus
Exhibit 77:Teva Pharmaceutical Industries - Key offerings
Exhibit 78:Teva Pharmaceutical Industries - Key customers
Exhibit 79:TSUMURA - Vendor overview
Exhibit 80:TSUMURA - Business segments
Exhibit 81:TSUMURA - Organizational developments
Exhibit 82:TSUMURA - Key offerings
Exhibit 83:TSUMURA - Key customers
Exhibit 84:Research framework
Exhibit 85:Validation techniques employed for market sizing
Exhibit 86:Information sources
Exhibit 87:List of abbreviations

発刊日

2018/11/22

体裁

PDF / 112ページ

販売価格

2,500USD

発行

TechNavio

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品原料・製剤 / 創薬一般 / 疾病別治療・領域別治療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE